Live: ACHEMA Opening Day Report
The majority of the PTE team is in attendance at ACHEMA. Our editor, Dr Jo Watts, gives her opinion on how the first day of the show went and what her expectations are for the rest of the week.
In 2009 there were 3767 exhibitors and more than 173000 visitors to ACHEMA in Frankfurt. The 2012 event looks to be even bigger. The hot topics for this year are energy and resources, while congress topics will address process engineering, pharmaceutical production and biotechnology. On the opening day, I saw a variety of new technologies for the pharma industry.
Lock showcased a gravity fall metal detection system that promises a greater product integrity for API manufacturers. They also have a bottlecheck system that incorporates an 'OPTIX' detector that inspects bottles of tablets and capsules at the end of the packaging line.
Thomas Homann of GEA showed me a separator for the recovery of vaccines and pharmaceutical proteins in lab scale and pilot plant applications. It operates at 20000G, which is unique worldwide. There are three bowl sizes, 15-30 L/h up to 150-300L/h. Of course, it is a sterile system that meets GMP requirements.
Merck Millipore have the only complete single-use process train that promises scalable, industry standard separation and purification technologies. The highest level of flexibility for multi-product, multi-scale facilities with modular units for scaling up, down and across unit operations.
More news to come soon!
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
